A real-world disproportionality analysis of mesalazine data mining of the public version of FDA adverse event reporting system

Overview of attention for article published in Frontiers in Pharmacology, January 2024

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,890 followers.

New Research: A real-world disproportionality analysis of mesalazine data mining of the public version of FDA adverse event reporting system https://t.co/7oecgMTU3a #pharmacology

31 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.